Entera Bio Ltd. (ENTX) vs YD Bio Limited (YDES)

Entera Bio Ltd. and YD Bio Limited are both Biotechnology companies. Entera Bio Ltd. and YD Bio Limited are of similar size ($476.8M and $462.4M).

Valuation

Metric ENTX YDES Biotechnology median
P/E n/m — 8.56
P/S 599.53 — 10.17
P/B 18.40 — 2.34
Price to free cash flow n/m — 20.42
EV/EBITDA n/m — 0.69
EV/Sales 534.34 — 9.64
Earnings yield (13.21%) — (29.41%)
Free cash flow yield (8.22%) — (23.50%)

Profitability

Metric ENTX YDES Biotechnology median
Gross margin 0.00% — 65.16%
Operating margin 0.00% — 0.00%
Net margin 0.00% — 0.00%
Free cash flow margin 0.00% — 0.00%
Return on equity (138.92%) — (56.66%)
Return on assets (87.02%) — (49.22%)
Return on invested capital 0.00% — 0.00%

Growth

Metric ENTX YDES Biotechnology median
Revenue growth (TTM) 66.42% — 5.64%
EPS growth (last fiscal year) 0.00% — 30.08%
Revenue growth, 5-year CAGR (29.19%) — 9.41%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric ENTX YDES Biotechnology median
Debt to equity 0.00 — 0.00
Current ratio 8.98 — 4.72
Net debt to EBITDA 1.29 — 0.96

Dividend

Metric ENTX YDES Biotechnology median
Dividend yield — — 0.08%
Payout ratio — — —

Size

Metric ENTX YDES Biotechnology median
Market cap 462.40m 476.77m 151.40m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack